Anaptysbio Inc (ANAB)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 03-2016 | 12-2015 | 12-2014 | 12-2013 | |
| Assets | ||||
| Current Assets | ||||
| Cash & Cash Equivalents | 0 | 51,680 | 22,180 | 2,810 |
| Receivables | 0 | 1,220 | 1,450 | 0 |
| Other current assets | 0 | 560 | 770 | 240 |
| TOTAL | $0 | $53,460 | $24,400 | $3,050 |
| Non-Current Assets | ||||
| PPE Net | N/A | 4,130 | 3,930 | 3,860 |
| Other Non-Current Assets | 0 | 2,260 | 80 | 110 |
| TOTAL | $N/A | $6,390 | $4,010 | $3,970 |
| Total Assets | $0 | $56,280 | $25,060 | $3,910 |
| Liabilities | ||||
| Current Liabilities | ||||
| Short Term Debt | 0 | 0 | 0 | 810 |
| Accounts payable and accrued liabilities | 0 | 1,520 | 410 | 190 |
| Accrued Expenses | 0 | 2,750 | 1,050 | 740 |
| Other current liabilities | 0 | 2,960 | 10,210 | 1,400 |
| TOTAL | $0 | $7,370 | $11,680 | $3,160 |
| Non-Current Liabilities | ||||
| Long Term Debt | 0 | 4,900 | 4,790 | 0 |
| Other Non-Current Liabilities | 0 | 1,540 | 560 | 380 |
| TOTAL | $N/A | $6,550 | $7,370 | $600 |
| Total Liabilities | $0 | $13,940 | $19,070 | $3,760 |
| Shareholders' Equity | ||||
| Common Shares | 0 | 3 | 10 | 10 |
| Retained earnings | 0 | -50,660 | -45,250 | -48,790 |
| Other shareholders' equity | 0 | 77,507 | 36,830 | 34,680 |
| TOTAL | $0 | $42,330 | $5,990 | $140 |
| Total Liabilities And Equity | $0 | $56,270 | $25,060 | $3,900 |